Skip to main content

INR for Individuals Taking Warfarin and Interacting Anti-Infective Medications

CBE ID
0556
1.4 Project
Patient Safety
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Spring 2019
Is Under Review
No
1.3 Measure Description

Percentage of episodes with an International Normalized Ratio (INR) test performed three to seven days after a newly started interacting anti-infective medication for individuals receiving warfarin

    • 1.14 Numerator

      Number of episodes in the denominator with an INR test performed three to seven days after the start date of an anti-infective medication

    • 1.15 Denominator

      Number of episodes with a newly started interacting anti-infective medication with an overlapping days’ supply of warfarin.

    • Exclusions

      We excluded the following individuals from the denominator:
      • Individuals with a diagnosis of cancer
      • Individuals who are monitoring INR at home

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Patient Safety Spring Cycle 2019
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Centers for Medicare & Medicaid Services
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      Limited proprietary coding is contained in the measure specifications for user convenience. Use of these codes may require permission from the code owner or agreement to a license.

      ICD-10 codes are copyright © World Health Organization (WHO), Fourth Edition, 2010. CPT © 2010 American Medical Association. CPT is a registered trademark of the American Medical Association. All rights reserved